| Summary: | Cancer incidence is increasing worldwide mainly due to changes in diet, life style and increased lifespan. In particular, liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality. Plant phytochemicals are a good and promising source of anticancer compounds. In a previous work, we reported the potential of ursolic acid (UA) to induce cell death and to inhibit proliferation in colorectal cancer cells [1]. This natural triterpenoid UA was also shown to activate JNK and to modulate molecular markers of autophagy (Xavier et al., unpublished data). In the present study, we tested the ability of two isomer triterpenoids, UA and oleanolic acid (OA), to induce cell death and modulate autophagy in human hepatocellular carcinoma cell line (HepG2 cells). For that, the effect of these phytochemicals on cell death was evaluated by MTT assay and propidium iodide staining, in complete and starvation medium. Autophagy markers were evaluated by western blot and fluorescent microscopy. Contrary to our previous data with other cell lines, HepG2 cells were less susceptible to UA and, unexpectedly, OA was a more potent inducer of cell death than UA. Interestingly, starvation-induced autophagy sensitized HepG2 cells to cell death caused by OA, but not by UA. The IC50 of OA decreased from 50 μM in complete medium to 3.5 μM in starvation medium. Although UA and OA increase the levels of autophagy markers LC3-II and p62, as well as the number of acidic vacuoles (as assessed by MDC staining), the cell death induced by OA was not prevented by inhibitors of autophagy and of lysosome proteases. Overall, the results seem to indicate that autophagy is not involved in cell death induced by OA. Interestingly, methyl-β-cyclodextrin (a polymer able to decrease membrane cholesterol content) prevented OA-induced cell death. In conclusion, these results seem to indicate that cellular membrane biophysics are affected by OA, in particular during starvation and with involvement of cholesterol, which leads to sudden cell death. In the future OA can be viewed as specific drug for cancer treatment in particular cell physiological conditions. Acknowledgements: This work is supported by FCT research grant NaturAge – PTDC/QUI-BIQ/101392/2008, which is co-funded by the program COMPETE from QREN with co-participation from the European Community fund FEDER. [1] Xavier et al., Cancer Letters, 2009, 281: 162-70.
|
|---|